Literature DB >> 22863562

PNPLA3 polymorphisms and liver aminotransferase levels in a Mexican American population.

Quan Li1, Hui-Qi Qu, Anne R Rentfro, Megan L Grove, Shaper Mirza, Yang Lu, Craig L Hanis, Michael B Fallon, Eric Boerwinkle, Susan P Fisher-Hoch, Joseph B McCormick.   

Abstract

PURPOSE: This study examined genetic associations of patatin-like phospholipase domain containing 3 gene (PNPLA3) polymorphisms and liver aminotransferases in an extensively documented, randomly recruited Mexican American population at high risk of liver disease.
METHODS: Two single nucleotide polymorphisms (SNP) in the PNPLA3 gene (i.e., rs738409 and rs2281135) were genotyped in 1532 individuals. Population stratification was corrected by the genotyping of 103 ancestry informative markers (AIMs) for Mexican Americans.
RESULTS: Both PNPLA3 SNPs showed highly significant association with alanine aminotransferase (ALT) levels, but was also, in males, associated with aspartate aminotransferase (AST) levels. Haplotypic association test of the two SNPs suggested stronger genetic association with rs738409 than rs2281135. Obvious sex effects were observed: rs738409-sex interaction in ALT levels P = 8.37 x 10(-4); rs738409-sex interaction in AST levels P = 5.03 x 10(-3).
CONCLUSIONS: This population study highlights a sex-specific association of PNPLA3 polymorphisms and elevated liver enzymes in a population-based study, independent of common pathological factors of the metabolic syndrome. The strong genetic association found in women ≤ 50 years old, but not in women > 50 years old, suggests that sex hormones may mediate the sex effect.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22863562      PMCID: PMC3441048          DOI: 10.25011/cim.v35i4.17153

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  33 in total

1.  I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.

Authors:  Luca Valenti; Anna Alisi; Enrico Galmozzi; Andrea Bartuli; Benedetta Del Menico; Arianna Alterio; Paola Dongiovanni; Silvia Fargion; Valerio Nobili
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

2.  Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease.

Authors:  Shiobhan R Weston; Wendy Leyden; Rose Murphy; Nathan M Bass; Beth P Bell; M Michele Manos; Norah A Terrault
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

3.  Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways.

Authors:  Tara M D'Eon; Sandra C Souza; Mark Aronovitz; Martin S Obin; Susan K Fried; Andrew S Greenberg
Journal:  J Biol Chem       Date:  2005-08-17       Impact factor: 5.157

4.  The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.

Authors:  Yaron Rotman; Christopher Koh; Joseph M Zmuda; David E Kleiner; T Jake Liang
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

5.  Adiponectin/leptin ratio and metabolic syndrome in a Mexican American population.

Authors:  Shaper Mirza; Hui-Qi Qu; Quan Li; Perla J Martinez; Anne R Rentfro; Joseph B McCormick; Susan P Fisher-Hoch
Journal:  Clin Invest Med       Date:  2011-10-01       Impact factor: 0.825

6.  Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

Authors:  Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

Review 7.  Biological effects of lysophospholipids.

Authors:  R Rivera; J Chun
Journal:  Rev Physiol Biochem Pharmacol       Date:  2008       Impact factor: 5.545

8.  Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities.

Authors:  Christopher M Jenkins; David J Mancuso; Wei Yan; Harold F Sims; Beverly Gibson; Richard W Gross
Journal:  J Biol Chem       Date:  2004-09-10       Impact factor: 5.157

9.  Prevalence of metabolic syndrome and risks of abnormal serum alanine aminotransferase in Hispanics: a population-based study.

Authors:  Jen-Jung Pan; Hui-Qi Qu; Anne Rentfro; Joseph B McCormick; Susan P Fisher-Hoch; Michael B Fallon
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

10.  The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning.

Authors:  Hui-Qi Qu; Quan Li; Anne R Rentfro; Susan P Fisher-Hoch; Joseph B McCormick
Journal:  PLoS One       Date:  2011-06-14       Impact factor: 3.240

View more
  21 in total

1.  Genetic variants in COL13A1, ADIPOQ and SAMM50, in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population.

Authors:  Elena Larrieta-Carrasco; Yvonne N Flores; Luis R Macías-Kauffer; Paula Ramírez-Palacios; Manuel Quiterio; Eric G Ramírez-Salazar; Paola León-Mimila; Berenice Rivera-Paredez; Guillermo Cabrera-Álvarez; Samuel Canizales-Quinteros; Zuo-Feng Zhang; Tania V López-Pérez; Jorge Salmerón; Rafael Velázquez-Cruz
Journal:  Exp Mol Pathol       Date:  2018-01-04       Impact factor: 3.362

2.  Liver and Other Gastrointestinal Cancers Are Frequent in Mexican Americans.

Authors:  Ariana L Garza; Kristina P Vatcheva; Jen-Jung Pan; Mohammad H Rahbar; Michael B Fallon; Joseph B McCormick; Susan P Fisher-Hoch
Journal:  J Racial Ethn Health Disparities       Date:  2015-03-28

3.  Association between PNPLA3 (rs738409), LYPLAL1 (rs12137855), PPP1R3B (rs4240624), GCKR (rs780094), and elevated transaminase levels in overweight/obese Mexican adults.

Authors:  Yvonne N Flores; Rafael Velázquez-Cruz; Paula Ramírez; Manuel Bañuelos; Zuo-Feng Zhang; Hal F Yee; Shen-Chih Chang; Samuel Canizales-Quinteros; Manuel Quiterio; Guillermo Cabrera-Alvarez; Nelly Patiño; Jorge Salmerón
Journal:  Mol Biol Rep       Date:  2016-10-17       Impact factor: 2.316

4.  Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.

Authors:  Qin Pan; Rui-Nan Zhang; Yu-Qin Wang; Rui-Dan Zheng; Yu-Qiang Mi; Wen-Bin Liu; Feng Shen; Guang-Yu Chen; Jia-Fa Lu; Chan-Yan Zhu; Shu-Yi Zhang; Yi-Ming Chen; Wan-Lu Sun; Jian-Gao Fan
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

5.  Exploring multiple quantitative trait loci models of hepatic fibrosis in a mouse intercross.

Authors:  Rabea A Hall; Sonja Hillebrandt; Frank Lammert
Journal:  Mamm Genome       Date:  2015-11-07       Impact factor: 2.957

6.  PNPLA3 I148M polymorphism is associated with elevated alanine transaminase levels in Mexican Indigenous and Mestizo populations.

Authors:  Elena Larrieta-Carrasco; Victor Acuña-Alonzo; Rafael Velázquez-Cruz; Rodrigo Barquera-Lozano; Paola León-Mimila; Hugo Villamil-Ramírez; Marta Menjivar; Sandra Romero-Hidalgo; Nahúm Méndez-Sánchez; Vanessa Cárdenas; Manuel Bañuelos-Moreno; Yvonne N Flores; Manuel Quiterio; Jorge Salmerón; Fausto Sánchez-Muñoz; Teresa Villarreal-Molina; Carlos A Aguilar-Salinas; Samuel Canizales-Quinteros
Journal:  Mol Biol Rep       Date:  2014-04-02       Impact factor: 2.316

7.  Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer's disease and myocardial infarction.

Authors:  Nicholette D Palmer; Bratati Kahali; Annapurna Kuppa; Yanhua Chen; Xiaomeng Du; Mary F Feitosa; Lawrence F Bielak; Jeffrey R O'Connell; Solomon K Musani; Xiuqing Guo; Albert V Smith; Kathleen A Ryan; Gudny Eirksdottir; Matthew A Allison; Donald W Bowden; Matthew J Budoff; J Jeffrey Carr; Yii-Der I Chen; Kent D Taylor; Adolfo Correa; Breland F Crudup; Brian Halligan; Jian Yang; Sharon L R Kardia; Lenore J Launer; Yi-Ping Fu; Thomas H Mosley; Jill M Norris; James G Terry; Christopher J O'Donnell; Jerome I Rotter; Lynne E Wagenknecht; Vilmundur Gudnason; Michael A Province; Patricia A Peyser; Elizabeth K Speliotes
Journal:  Hum Mol Genet       Date:  2021-07-09       Impact factor: 6.150

Review 8.  Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases.

Authors:  Winston Hernández-Ceballos; Jacqueline Cordova-Gallardo; Nahum Mendez-Sanchez
Journal:  J Clin Transl Hepatol       Date:  2021-03-08

9.  PNPLA3 Genotype, Arachidonic Acid Intake, and Unsaturated Fat Intake Influences Liver Fibrosis in Hispanic Youth with Obesity.

Authors:  Roshonda B Jones; Lide Arenaza; Claudia Rios; Jasmine F Plows; Paige K Berger; Tanya L Alderete; Jennifer L Fogel; Krishna Nayak; Passant Mohamed; Darryl Hwang; Suzanne Palmer; Frank Sinatra; Hooman Allayee; Rohit Kohli; Michael I Goran
Journal:  Nutrients       Date:  2021-05-12       Impact factor: 5.717

10.  A frequent PNPLA3 variant is a sex specific disease modifier in PSC patients with bile duct stenosis.

Authors:  Kilian Friedrich; Christian Rupp; Johannes Roksund Hov; Niels Steinebrunner; Karl-Heinz Weiss; Adolf Stiehl; Maik Brune; Petra Kloeters Yvonne Schaefer; Peter Schemmer; Peter Sauer; Peter Schirmacher; Heiko Runz; Tom Hemming Karlsen; Wolfgang Stremmel; Daniel Nils Gotthardt
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.